Clinical Trial Update: Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating αPD1-MSLN-CAR T cells in MSLN-positive advanced solid tumors; status not disclosed in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• αPD1-MSLN-CAR T cells

Snippet

Sponsor: Shanghai Cell Therapy Group Co.,Ltd | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN